Tuberculosis preventive therapy: scientific and ethical considerations for trials of ultra-short regimens.

Saved in:
Bibliographic Details
Title: Tuberculosis preventive therapy: scientific and ethical considerations for trials of ultra-short regimens.
Authors: Walker TM; Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK. Electronic address: timothy.walker@ndm.ox.ac.uk., Watson JA; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford, UK; Infectious Diseases Data Observatory, Oxford, UK., Moore DAJ; Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK., Frick M; Treatment Action Group, New York, NY, USA., Jamrozik E; Ethox and Pandemic Sciences Institute, University of Oxford, Oxford, UK; Department of Infectious Diseases & Royal Melbourne Hospital Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2025 Jul; Vol. 25 (7), pp. e432-e438. Date of Electronic Publication: 2025 Mar 22.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-4457
DOI:10.1016/S1473-3099(25)00083-0